Share the Video:

Clinical Progress of a Novel Serotonergic Psychedelic Therapeutic (RE104) for Postpartum Depression and Adjustment Disorder

Beatrix Taylor

This presentation will cover an overview and progress of Reunion clinical trial related activities including an update on the ongoing RECONNECT Phase 2 study in postpartum depression and an introduction to the development and design of the REKINDLE Phase 2 study in adjustment disorder. Reunion will also provide an update on the timing of data release and upcoming corporate milestones.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Related Videos

The Library is Open: A Conversation about Queer-Affirming Psychedelic Therapy

Terence Ching, Ph.D., Jessalyn Maguire, Justin Natoli, Shveta Mittal, PhD, Syre Saniyah, T Veiga, Jae Sevelius, Alan Davis

A Queer Path to Wellness: A Longitudinal Investigation of Ayahuasca’s Impact on LGBTQIA+ Psychological Health and Well-being

Matthew X Lowe

Women’s’ Biology and Psychedelics: Safety, Efficacy and Opportunity

Grace Blest-Hopley

Decoding the Menstrual Cycle: Empowering Women with Psychedelics and Data-Driven Research

Mia Cosco

The Impact of Psilocybin Use on Parenting: A Maternal Perspective

Amanda Elmore

Improving standardization and reducing bias in psychedelic drug development trials using an AI-enabled platform

Danielle Schlosser, Jennifer Tippett

Technology Across the Psychedelic Continuum

Matias Serebrinsky, Julie Simon, Danielle Schlosser, Lucia Huang

Scaling the Infrastructure for FDA-Approved Psychedelics

Stacey Wallin, Jonathan Sabbagh, Steven Levine, Geoffrey Grammer

Plant Power to the People: Healing Black and Melanated Minds and Souls

Imani Turnbull-Brown, Julian Fontaine Fox